> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Review Pre-Pen Plus Skin Test
- URL: https://www.fdaweb.com/panel-to-review-pre-pen-plus-skin-test/
- Published: 2019-01-31T12:00:00.000Z
- Updated: 2026-09-15T00:59:20.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5143273

*Federal Register* notice: FDA has announced a 3/27 Pulmonary-Allergy Drugs Advisory Committee meeting. Panel members are scheduled to discuss an AllerQuest NDA for Pre-Pen Plus, a skin-test kit that combines the approved product Pre–Pen (benzylpenicilloyl polylysine for injection) with penicillin G potassium, penicilloic acid, penilloic acid, and amoxicillin sodium, for the proposed indication of detecting IgE sensitization to penicillin antigens and reliably rule out the potential for immediate life-threatening penicillin allergic reactions with a high degree of probability in patients with history of possible IgE-dependent penicillin allergy. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-01-31/pdf/2019-00492.pdf?ref=fdaweb.com).